Blog for Global Lipid Nanoparticles and Non-Viral Delivery Vehicles

  • Ms. Ginger Smith Fills the Vital Role of Director of Quality Assurance at T&T Scientific

    T&T Scientific is excited to add another critical expert to its management team and to introduce Ms. Ginger Smith, its new Director of Quality Assurance. We are so fortunate that she has enthusiastically accepted to join our organization to fill this vital management role immediately.

    Before joining T&T Scientific, Ms. Smith directed projects and research for biotech manufacturing, working directly with regulatory consultants from the United States, Canada, and Europe (ECHA). Ms. Smith has worked alongside executive leadership, the internal Science Medical Advisory Board, and all levels of management in establishing workflow processes, projects, and corporate policies. Worked with each department to acquire accurate reports, and establish realistic timelines and results regarding scientific testing.

  • T&T Scientific Add's a New Operation Chief for Improved Efficiency, Effectiveness, and Quality of Its Execution of Partnerships, GMP Manufacturing, as well as Novel New Formulation and Manufacturing Technologies

    We are thrilled to introduce T&T Scientific’s new operation lead, Dr. Venkata M. Yenugonda, part of one of the earliest research groups worldwi...
  • Dr. Drishti Sehgal Joins T&T Scientific

    We are thrilled to introduce our new Director of Quality Control and Analytics, who has joined T&T Scientific, Dr. Drishti Sehgal. T&T is genuinely fortunate to add such a talented and proven-record scientist who has specialized in all and beyond analytical methods used previously to develop drug products at T&T Scientific. Drishti will (has already started to) lead the Quality Control (QC) and Analytics for all, especially clinical GMP projects, as she is building her team within the department. We are grateful for this significant advancement in our Quality Control (QC) department. Drishti and her husband have started the process of moving to Knoxville and she has officially started her work at our great organization. Drishti, holding a doctoral of pharmaceutics from the University of Minnesota, is a highly experienced, goal-oriented, and driven pharmaceutical scientist with experience in closely related fields in the industry; and professionally passionate about research, development, and innovation. In a broad spectrum, she has experience across multiple modalities, pharmaceutical formulations and gene therapies, proteins, polymer/lipid nanoparticles, cell and antibody engineering, antibody-drug conjugate, and cell-based therapy and immunotherapy. Not only her technical proven track record is confirming, but also her admiring and successful management of leading her entire team during her post-doctoral studies at Temple University. She embraces working in a highly competitive, innovative, and productive workplace with an energetic and supportive environment for career growth and advancement. 

     

    We are thrilled to introduce our new Director of Quality Control and Analytics, who has joined T&T Scientific, Dr. Drishti Sehgal. T&T is genuinely fortunate to add such a talented and proven-record scientist who has specialized in all and beyond analytical methods used previously to develop drug products at T&T Scientific. Drishti will (has already started to) lead the Quality Control (QC) and Analytics for all, especially clinical GMP projects, as she is building her team within the department. We are grateful for this significant advancement in our Quality Control (QC) department. Drishti and her husband have started the process of moving to Knoxville and she has officially started her work at our great organization. Drishti, holding a doctoral of pharmaceutics from the University of Minnesota, is a highly experienced, goal-oriented, and driven pharmaceutical scientist with experience in closely related fields in the industry; and professionally passionate about research, development, and innovation. In a broad spectrum, she has experience across multiple modalities, pharmaceutical formulations and gene therapies, proteins, polymer/lipid nanoparticles, cell and antibody engineering, antibody-drug conjugate, and cell-based therapy and immunotherapy. Not only her technical proven track record is confirming, but also her admiring and successful management of leading her entire team during her post-doctoral studies at Temple University. She embraces working in a highly competitive, innovative, and productive workplace with an energetic and supportive environment for career growth and advancement.   #genetherapy  #mrna #lipids #formulations #pharmaceuticals #analytical #cdmo #management #team #innovation #pharmaceutical #experience #career #work #immunotherapy #development #growth #genetherapy  #mrna #lipids #formulations #pharmaceuticals #analytical #cdmo #management #team #innovation #pharmaceutical #experience #career #work #immunotherapy #development #growth

  • Merry Christmas from T&T Scientific

    From T&T Scientific, we wish you a Merry Christmas and Happy Holidays, and wish all of you prosperity, peace, great health, happiness, and succ...
  • RNA Lipid Nanoparticles

    As pharmaceutical field is emerging day by day and in order to produce vaccines there are certain ways for vaccine developers which are as followin...
  • Lipid Nanoparticles (LNPs) for Therapeutics and Vaccines

    The era of COVID-19 has brought to the forefront mRNA-based vaccines.  With the EUA approval of Pfizer and Moderna’s vaccines, the technology which...
  • Dr. Gaurav Sahay: Lipid Nanoparticles for Delivery of mRNA Therapeutics and Vaccines

    Dr. Gaurav Sahay: Lipid Nanoparticles for Delivery of mRNA T...
  • Delivering Clinical Breakthroughs by Lipid Nanoparticles

                                                                                 
  • Pfizer BioNTech Covid-19 Lipid Nanoparticle Components and Vaccine Administration

    In 2020-2021, the lipid nanoparticles (LNPs) emphasized as the forefront of science and technology when Pfizer/BioNTech and Moderna vaccines used ...
  • COVID-19 Vaccines and the Role of Lipid Nanoparticles Delivery

    mRNA vaccines are using a promising technology and an alternative option to conventional vaccine approaches. Some of their benefits include their ...
  • Messenger Ribonucleuc Acid (mRNA)

  • Overview of Pharmaceutical Drug Discovery and Development

    Established and defined by the US Food and Drug Administration (US-FDA), drug development includes the five stages below: Discovery and Developme...